-
Colorectal Cancer Awareness Month: ‘We Have Work to Do’
Colorectal cancer expert John Marshall, M.D., shares his feelings about the month of March, which is Colorectal Cancer Awareness month.
Category: News
-
Colorectal Cancer Alliance-Funded Research among First to Examine Relationship between Colon Microbiota and Colorectal Cancer
National nonprofit Colorectal Cancer Alliance will invest $125,000 in innovative, peer-reviewed research by Georgetown Lombardi Comprehensive Cancer Center’s Benjamin Weinberg, MD, as part of its Chris4Life Research Program, which funds research in young-onset colorectal cancer and other areas.
Category: News
-
She Thought the Stomach Cramps Were from Her Food Truck Diet. At 33, She Was Diagnosed with Stage 4 Colon Cancer
“You always read in magazines, ‘I never thought it’d happen to me.’ And now I’m that person in the magazine.”
Category: News
-
Pancreatic Cancer: Data With Liposomal Irinotecan/5-FU
John L. Marshall, MD, and Fadi Braiteh, MD, and share their perspectives on the approval of liposomal irinotecan and review data from the NAPOLI-1 trial in pancreatic cancer.
Category: News
-
Marshall Highlights Treatment Options for Left-Sided mCRC
John Marshall, MD, recently discussed the treatment options and decisions he makes when treating patients with metastatic colorectal cancer.
Category: News
-
Colorectal Cancer in Young Adults: An ‘Issue Screaming for Action’
Dr John Marshall speaks to Dr Thomas Weber at the Ruesch Center Symposium about the increasing incidence of colorectal cancer in young adults and simple steps that clinicians can take to slow this disturbing trend.
Category: News
-
Pancreatic Cancer Case Studies Case-Based Peer Perspectives > Pancreatic Cancer > Case Studies: Improving the Treatment of Locally Advanced Pancreatic Cancer
Expert John Marshall, MD, reviews the case of a 64-year-old woman who presents with locally advanced pancreatic adenocarcinoma and shares insight on optimal diagnostic workup and molecular analysis techniques.
Category: News
-
Dr. Pishvaian on Implications of Entrectinib Study in Pancreatic Cancer
Michael Pishvaian, MD, PhD, discusses the implications of a study of entrectinib in patients with metastatic pancreatic cancer.
Category: News
-
Dosing Options With Nab-Paclitaxel/Gemcitabine
John L. Marshall, MD, and Fadi Braiteh, MD, discuss the importance of considering sequencing strategies prior to choosing a frontline regimen in pancreatic cancer.
Category: News
-
Living Well with a GI Cancer
In this special CURE Connections® video, developed in partnership with The Ruesch Center, patients and caregivers who have navigated through the diagnosis of a gastrointestinal cancer reflect on ways in which they have managed challenges during the cancer journey, reminding viewers to seek out support and remain positive.
Category: News